A lymphangioma that occurs around the head and neck, the armpits, or the groin and contains clear fluid. Cystic hygromas are usually present from birth and disappear naturally from the age of about 2.
This is the most common serious genetic disease in Caucasian children, with an incidence of about one per 2,500 births, and more than 6,000 patients in the UK (30,000 in the USA). It is an autosomal recessive disorder of the mucus-secreting glands of the lungs, the pancreas, the mouth, and the gastrointestinal tract, as well as the sweat glands of the skin. The defective gene is sited on chromosome 7 which encodes for a protein, cystic ?brosis transmembrane conductance regulator (CFTR). Individuals who inherit the gene only on one set of chromosomes can, however, carry the defect into successive generations. Where parents have a child with cystic ?brosis, they have a one-infour chance of subsequent children having the disease. They should seek GENETIC COUNSELLING.
The disorder is characterised by failure to gain weight in spite of a good appetite, by repeated attacks of bronchitis (with BRONCHIECTASIS developing at a young age), and by the passage of loose, foul-smelling and slimy stools (faeces). AMNIOCENTESIS, which yields amniotic ?uid along with cells shed from the fetus’s skin, can be used to diagnose cystic ?brosis prenatally. The levels of various enzymes can be measured in the ?uid and are abnormal when the fetus is affected by cystic ?brosis. Neonatal screening is possible using a test on blood spots – immunoreactive trypsin (IRT).
In children with symptoms or a positive family history, the disease can be tested for by measuring sweat chloride and sodium. This detects the abnormal amount of salt that is excreted via the sweat glands when cystic ?brosis is present. Con?rmation is by genetic testing.
Treatment This consists basically of regular physiotherapy and postural drainage, antibiotics and the taking of pancreatic enzyme tablets and vitamins. Some children need STEROID treatment and all require nutritional support. The earlier treatment is started, the better the results. Whereas two decades ago, only 12 per cent of affected children survived beyond adolescence, today 75 per cent survive into adult life, and an increasing number are surviving into their 40s. Patients with end-stage disease can be treated by heart-lung transplantation (with their own heart going to another recipient). Research is underway on the possible use of GENE THERAPY to control the disorder. Parents of children with cystic ?brosis, seeking help and advice, can obtain this from the Cystic Fibrosis Trust.... cystic fibrosis
A pathological rather than a clinical entity. The term refers to the replacement of BONE by a highly cellular and vascular connective tissue. It is the result of osteoclastic and osteoblastic activity and is due to excessive PARATHYROID activity. It is thus seen in a proportion of patients with primary hyperparathyroidism and in patients with uraemic osteodystrophy; that is, the secondary hyperparathyroidism that occurs in patients with chronic renal disease.... osteitis fibrosa cystica
a collection of fluid behind the neck of a fetus, occasionally extending laterally to involve the sides of the neck (see hydrops fetalis). In its mildest form it is evidenced by an increased nuchal translucency (see nuchal translucency scanning). Cystic hygroma may be a diagnostic feature of chromosomal abnormality (e.g. Down’s syndrome, Turner’s syndrome).... cystic hygroma
Health Encyclopedia